Ceremorphic set to use analog circuit tech for drug discovery

Swati Bharadwaj / Oct 21, 2023, 08:23 IST

Text Size

Small
Medium
Large

Ceremorphic set to use analog circuit tech for drug discovery

Hyderabad: Fabless silicon and system development player Ceremorphic Inc, which has its innovation centre in Hyderabad, is foraying into the lifesciences space.
Ceremorphic is setting up a new division called Ceremorphic Life Sciences that will focus on taking away one of pharma sector’s biggest pain points — expensive and long drawn drug discovery process — with the help of analog computing technology, Ceremorphic founder & CEO Dr Venkat Matella told TOI here.

Matella said Ceremorphic has designed an in silico (experiment done using computer simulation) architecture using its proprietary analog circuit technology, supercomputing chips and novel AI algorithms that can predict later stage outcomes to increase R&D efficiency.
The startup has designed a circuit, using analog technology, that will simulate a human cell. This circuit or simulated human cell will sit on a 16nm chip which will be used for speeding up drug discovery and development.

“This innovation will transform the future of drug discovery and make personalised medicine a reality as accurate AI foundation models, new novel algorithms and relevant data are critical to producing successful later stage results,” he added.
He said Ceremorphic’s platform would be able to develop new drugs in just 2-3 years and at about one-tenth of the existing costs.

We also published the following articles recently

Chip design co Ceremorphic to foray into life sciences, use analog circuit tech to power new drug discovery
Ceremorphic Inc, a fabless silicon and system development company, is entering the life sciences sector with the launch of Ceremorphic Life Sciences. The division will use analog computing technology to address the challenges of expensive and time-consuming drug discovery. Ceremorphic has developed an in silico architecture using analog circuit technology, supercomputing chips, and AI algorithms to predict later-stage outcomes and increase R&D efficiency. The company's platform aims to accelerate drug discovery, development, and selectivity, potentially reducing development time and costs. Ceremorphic plans to conduct clinical trials and manufacture drugs in collaboration with external partners.

New ChatGPT-like AI tool for scientific discovery launched
An international team of scientists has launched a research collaboration called Polymathic AI, which aims to develop an AI-powered tool for scientific discovery. Unlike ChatGPT, which deals with words and sentences, Polymathic AI will learn from numerical data and physics simulations to aid scientists in modeling various phenomena, from supergiant stars to the Earth's climate. The project's goal is to improve the use of AI and machine learning in scientific research by uncovering commonalities and connections between different fields. The team plans to make their work transparent and open to democratize AI for scientific analyses in the future.

Scientists unveil ultra-hot ice discovery in outer solar system giants
Scientists have discovered a new phase of high-density ice, called Ice XIX, in the extreme conditions of Uranus and Neptune. This breakthrough could provide insights into the mysterious magnetic fields observed around these gas giants. Using advanced technology, researchers recreated the intense pressures and temperatures on these planets and identified the previously unknown Ice XIX phase. This unique form of ice has densely packed oxygen atoms and enhanced electrical conductivity, which may help explain the enigmatic magnetic fields detected by NASA's Voyager II spacecraft.

End of Article